Results 211 to 220 of about 260,112 (235)

Small and Innovative Molecules as New Strategy to Revert MDR

Frontiers in Oncology, 2014
Nicola Antonio Colabufo, Marcello Leopoldo, Marialessandra Contino   +2 more
exaly  

The MDR-TB epidemic—a status report

The International Journal of Tuberculosis and Lung Disease, 2019
C. R. Horsburgh, C. D. Mitnick, C. Lange
openaire   +1 more source

MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers

Pharmacological Research, 2017
Maryam A Shetab Boushehri
exaly  

Treatment of Infections Due to MDR Gram-Negative Bacteria

Frontiers in Medicine, 2019
Matteo Bassetti, Antonio Vena, Maddalena Peghin   +2 more
exaly  

Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)

BJU International, 2001
B R Birch, M C Hayes
exaly  

Fighting MDR-TB.

RN, 1993
openaire   +1 more source

MDR-1, but notMDR-3gene expression, is associated with unmutated IgVHgenes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia

Leukemia and Lymphoma, 2006
Mark Catherwood, Martin Clynes
exaly  

Secrets of MDR-TB revealed

Nature Reviews Microbiology, 2014
openaire   +1 more source

Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

Oncogene, 2012
K-J Kim
exaly  

Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients

Journal of Infection, 2006
Mehdi Mirsaeidi, Moslem Bahadori, Ali Akbar Velayati   +2 more
exaly